MedTrace Logo

TACTIC Coronary Thrombus Aspiration With Cath Rx In Anterior Myocardial Infarction: A Randomized Control Trial.

NCT06887413 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2026-04-21

No results posted yet for this study

Summary

The aim of this study is to evaluate the impact of sustained thrombectomy with INDIGO ASPIRATION SYSTEM using CAT RX versus no thrombectomy during primary percutaneous coronary intervention (PPCI) on microvascular obstruction and infarct size, as measured by cardiovascular magnetic resonance (CMR) between 3 and 5 days post PPCI, in patients with anterior STEMI

Conditions

  • Anterior Myocardial Infarction

Interventions

PROCEDURE

THROMBOASPIRATION WITH INDIGO SYSTEM

Subjects randomized to the treatment arm will be treated with the CAT RX as previously described.

Sponsors & Collaborators

  • European Cardiovascular Research Center

    collaborator NETWORK

  • Ceric Sàrl

    lead INDUSTRY

Principal Investigators

  • Alaide Chieffo · San Raffaele Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-18
Primary Completion
2027-02-28
Completion
2027-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06887413 on ClinicalTrials.gov